Xcout Intel
Cirrus Therapeutics
Cirrus Therapeutics, Inc. is an early-stage biotechnology company that has raised seed funding for its therapeutic research operations.
Subscribe to see Cirrus Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cirrus Therapeutics at a glance
Cirrus Therapeutics is a biotech company headquartered in United States. Its most recent funding round, Seed, raised $14.7M in August 2026. Xcout tracks 7 named people at Cirrus Therapeutics, including Ying Kai Chan (CEO).
Cirrus Therapeutics leadership
- Ying Kai ChanCEO
- Andrew DickCo-founder and Chief Scientific Advisor
- Ying Kai ChanFounder
- Ying Kai ChanExecutive Officer
- Alexandra CantleyDirector
- Andrew DickDirector
1 more named person on record for Cirrus Therapeutics, with roles, board committees and tenure — see the full roster →
Cirrus Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $14.7M | 4 named | |
| Seed | $11M | 7 named | |
| SEC Form D filing | $6.7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Cirrus Therapeutics competitors
A few of Cirrus Therapeutics's closest competitors — see the full list of competitors and alternatives →
Pahr Therapeutics, Inc. is a biotechnology company focused on developing new treatments for pulmonary arterial hypertension (PAH). The company recently raised $14 million in seed funding to support its therapeutic development efforts.
Cold Start Therapeutics is a biopharmaceutical startup headquartered in San Diego, California. The company has raised early-stage funding to advance its therapeutic pipeline.
Nodal Therapeutics, Inc. is a biotechnology company seeking seed investment and co-development partnerships for its therapeutic pipeline.
Crystalys Therapeutics is a biotechnology research company headquartered in San Diego, California, dedicated to developing novel therapies to address significant unmet medical needs.
Aer Therapeutics, Inc. is a biotechnology research company based in North Carolina focused on targeting mucus to improve lung health.
Mitotherapeutix, LLC is a biotechnology company that develops small interfering RNA (siRNA) based therapeutics targeting difficult disease pathways. The company focuses on modulating mitochondrial metabolic activity by inhibiting a negative gene regulator to treat a wide array of diseases.
Get Cirrus Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cirrus Therapeutics in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access